tiprankstipranks
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
US Market
TAK
Takeda Pharmaceutical Company
RESEARCH TOOLSreports
Want to see TAK full AI Analyst Report?

Takeda Pharmaceutical Company (TAK) Financial Statements

1,355 Followers

Takeda Pharmaceutical Company Financial Overview

Takeda Pharmaceutical Company's market cap is currently $50.95B. The company's EPS TTM is $61.44; its P/E ratio is 41.70; and it has a dividend yield of 3.86%. Takeda Pharmaceutical Company is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is $0.19. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 4.78T¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T
Gross Profit¥ 2.44T¥ 3.00T¥ 2.83T¥ 2.78T¥ 2.46T
Operating Income¥ 573.04B¥ 342.59B¥ 214.07B¥ 490.50B¥ 460.84B
EBITDA¥ 1.34T¥ 1.21T¥ 1.14T¥ 1.28T¥ 1.18T
Net Income¥ 203.33B¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B
Balance Sheet
Cash & Short-Term Investments¥ 597.63B¥ 405.59B¥ 472.89B¥ 553.70B¥ 875.00B
Total Assets¥ 15.52T¥ 14.25T¥ 15.11T¥ 13.96T¥ 13.18T
Total Debt¥ 4.90T¥ 4.52T¥ 4.84T¥ 4.38T¥ 4.35T
Net Debt¥ 4.31T¥ 4.13T¥ 4.39T¥ 3.85T¥ 3.50T
Total Liabilities¥ 7.71T¥ 7.31T¥ 7.83T¥ 7.60T¥ 7.49T
Stockholders' Equity¥ 7.81T¥ 6.94T¥ 7.27T¥ 6.35T¥ 5.68T
Cash Flow
Free Cash Flow¥ 808.70B¥ 856.39B¥ 235.61B¥ 343.47B¥ 937.07B
Operating Cash Flow¥ 995.32B¥ 1.06T¥ 716.34B¥ 977.16B¥ 1.12T
Investing Cash Flow¥ -411.19B¥ -367.06B¥ -463.86B¥ -607.10B¥ -198.13B
Financing Cash Flow¥ -398.08B¥ -751.42B¥ -354.42B¥ -709.15B¥ -1.07T
Currency in JPY

Takeda Pharmaceutical Company Earnings and Revenue History

Income Statement >

Takeda Pharmaceutical Company Debt to Assets

Balance Sheet >

Takeda Pharmaceutical Company Cash Flow

Cash Flow >

Takeda Pharmaceutical Company Forecast EPS vs Actual EPS

Earnings >